The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Megna Michael R since 2022.
This trader's CIK number is 1464583.
At the time of last reporting, Megna Michael R was the CHIEF ACCOUNTING OFFICER of Kiniksa Pharmaceuticals International, Plc. (stock ticker symbol KNSA).
Also see all insider trading activities at Kiniksa Pharmaceuticals International, Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | KNSA | 0 | $0 | 69,909 | $2,044,698 | 89,163 | $1,010,724 |
| 2024 | KNSA | 0 | $0 | 23,431 | $512,982 | 30,096 | $250,908 |
| 2023 | KNSA | 0 | $0 | 9,316 | $178,215 | 21,068 | $129,306 |
| 2022 | KNSA | 0 | $0 | 0 | $0 | 4,006 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-09-03 | KNSA | Sale | 11,000 | 34.84 | 383,240 |
| 2025-09-01 | KNSA | Option Ex | 8,853 | .00 | 0 |
| 2025-09-02 | KNSA | Option Ex | 774 | .00 | 0 |
| 2025-09-03 | KNSA | Option Ex | 11,000 | 17.92 | 197,120 |
| 2025-08-04 | KNSA | Option Ex | 17,000 | 15.52 | 263,840 |
| 2025-08-04 | KNSA | Sale | 17,000 | 32.35 | 549,950 |
| 2025-06-03 | KNSA | Option Ex | 15,211 | 15.50 | 235,770 |
| 2025-06-03 | KNSA | Sale | 15,211 | 28.75 | 437,316 |
| 2025-05-07 | KNSA | Sale | 17,647 | 26.69 | 470,998 |
| 2025-05-07 | KNSA | Option Ex | 17,647 | 12.10 | 213,528 |
| 2025-04-07 | KNSA | Option Ex | 3,933 | .00 | 0 |
| 2025-04-01 | KNSA | Option Ex | 4,920 | .00 | 0 |
| 2025-03-16 | KNSA | Option Ex | 774 | .00 | 0 |
| 2025-03-12 | KNSA | Sale | 9,051 | 22.45 | 203,194 |
| 2025-03-12 | KNSA | Option Ex | 9,051 | 11.10 | 100,466 |
| 2024-11-27 | KNSA | Option Ex | 8,637 | 11.10 | 95,870 |
| 2024-11-27 | KNSA | Sale | 8,637 | 22.45 | 193,900 |
| 2024-11-29 | KNSA | Option Ex | 9 | 11.10 | 99 |
| 2024-11-29 | KNSA | Sale | 9 | 22.45 | 202 |
| 2024-10-04 | KNSA | Option Ex | 175 | .00 | 0 |
| 2024-04-08 | KNSA | Option Ex | 3,932 | .00 | 0 |
| 2024-04-01 | KNSA | Option Ex | 2,558 | .00 | 0 |
| 2024-02-28 | KNSA | Option Ex | 5,126 | 8.83 | 45,262 |
| 2024-03-01 | KNSA | Option Ex | 9,659 | 11.36 | 109,677 |
| 2024-02-28 | KNSA | Sale | 5,126 | 21.79 | 111,695 |
| 2024-03-01 | KNSA | Sale | 9,659 | 21.45 | 207,185 |
| 2023-12-19 | KNSA | Sale | 9,316 | 19.13 | 178,215 |
| 2023-12-19 | KNSA | Option Ex | 9,316 | 13.88 | 129,306 |
| 2023-10-04 | KNSA | Option Ex | 175 | .00 | 0 |
| 2023-09-01 | KNSA | Option Ex | 3,933 | .00 | 0 |
| 2023-09-02 | KNSA | Option Ex | 774 | .00 | 0 |
| 2023-04-10 | KNSA | Option Ex | 3,933 | .00 | 0 |
| 2023-03-20 | KNSA | Option Ex | 2,163 | .00 | 0 |
| 2023-03-16 | KNSA | Option Ex | 774 | .00 | 0 |
| 2022-03-21 | KNSA | Option Ex | 3,231 | .00 | 0 |
| 2022-03-16 | KNSA | Option Ex | 775 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Megna Michael R (CHIEF ACCOUNTING OFFICER of Kiniksa Pharmaceuticals International, Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.